Vidhisha Mulani,is a cancer clinical research scientist known for her client-focused approach to advancing health equity. She has collaborated with clinical research professionals and executives, senior cancer clinical research oncologists at top ranked institutions in New York City, CRO's and pharmaceutical companies to design and scale inclusive clinical trials that improve patient recruitment and access for underserved populations. With experience at top institutions like Memorial Sloan Kettering, NYU Langone Health, Columbia University and Weill Cornell Medicine, spanning over 8 years, Vidhisha has streamlined over 50 trials, improving care for more than 100,000 patients across underserved areas in New York City. Her strong emotional intelligence and empathy ensure tailored, actionable solutions that meet client needs. Vidhisha's educational experience where she holds multiple graduate degrees from NYU and Columbia University in Clinical Research Science and Chronic Disease Epidemiology, along with undergraduate education in pharmaceutical sciences from Massachusetts College Of Pharmacy & Health Sciences University (MCPHS U) Boston, have made her one of the key visionaries in clinical research. 

Looking ahead, Vidhisha envisions EQ Trial Network as a pioneering force in revolutionizing clinical trial design and healthcare accessibility. By integrating advanced technologies like AI, she aims to enhance trial scalability and ensure that life-saving treatments reach underserved populations. Her goal is to drive systemic change in healthcare delivery, positioning EQ Trial Network as a leader in inclusive, data-driven clinical research.